Browsing by Subject "Surveillance"

Now showing items 1-4 of 4

    • Article  

      Current management of stage I testicular non-seminomatous germ cell tumours 

      Pectasides, Dimitrios; Pectasides, E.; Constantinidou, Anastasia; Aravantinos, Gerasimos (2009)
      Testicular germ cell tumors represent the most common malignancies in young males between the ages of 15 and 35; 50% of those with non-seminomatous germ cell tumors (NSGCT) have clinical stage I at diagnosis. Predictors ...
    • Article  

      The human immunodeficiency virus continuum of care in European Union Countries in 2013: Data and Challenges 

      Gourlay, Annabelle; Noori, T.; Pharris, Anastasia; Avdicova, Maria; Costagliola, Dominique; Cowan, Susan; Croxford, Sara; Monforte, A. D'arminio; Amo, Julia del; Delpech, Valerie; Diaz, Alejandro; Girardi, Enrico; Gunsenheimer-Bartmeyer, Barbara; Hernando, Victoria; Jose, Sophie; Leierer, Gisela; Nikolopoulos, Georgios K.; Obel, N.; Coul, E. Op De; Paraskeva, D.; Reiss, P.; Sabin, C.; Sasse, A.; Schmid, D.; Sonnerborg, A.; Spina, A.; Suligoi, B.; Supervie, V.; Touloumi, G.; Beckhoven, D. Van; Sighem, A. Van; Vourli, G.; Zangerle, R.; Porter, K. (2017)
      Background. The Joint United Nations Programme on HIV/AIDS (UNAIDS) has set a "90-90-90" target to curb the human immunodeficiency virus (HIV) epidemic by 2020, but methods used to assess whether countries have reached ...
    • Article  

      New technologies in predicting, preventing and controlling emerging infectious diseases 

      Christaki, Eirini (2015)
      Surveillance of emerging infectious diseases is vital for the early identification of public health threats. Emergence of novel infections is linked to human factors such as population density, travel and trade and ecological ...
    • Article  

      Stage I testicular seminoma: Management and controversies 

      Pectasides, Dimitrios; Pectasides, E.; Constantinidou, Anastasia; Aravantinos, Gerasimos (2009)
      Seminomas constitute more than half of testicular germ-cell tumours and 70-80% of patients with seminoma present with clinical stage I disease. Post-orchiectomy, management options include irradiation, surveillance or ...